Merck Pill

• Merck’s antiviral COVID-19 pill approved by U.S. FDA for at-home use

  Merck's drug, molnupiravir, developed with Ridgeback Biotherapeutics, was shown to reduce COVID-19 hospitalizations and deaths by around 30 per cent.

  World

  Dec 23, 2021
  
• Merck to make its COVID-19 antiviral pill in Canada, company announces

  Merck has reached an agreement with an Ontario pharmaceutical company to make its oral COVID-19 treatment, molnupiravir, in Canada, officials said Monday.

  Health

  Dec 6, 2021
  
• Advertisement
• Canada secures orders of Merck, Pfizer COVID-19 antiviral pills

  Canada has announced it has signed purchasing agreements with Pfizer and Merck for their COVID-19 antiviral pills designed to treat the virus.

  Health

  Dec 3, 2021
• Advertisement
• Merck’s COVID-19 pill reduces hospitalization, death risk by 30%, company says

  The company said the data on the drug molnupiravir had been submitted to the U.S. Food and Drug Administration ahead of a meeting of its expert advisers on Tuesday.

  Health

  Nov 26, 2021
• U.K. says it will roll out drug trial for Merck antiviral COVID-19 pill

  Last week Britain became the first country in the world to approve the potentially game-changing COVID-19 antiviral pill.

  Health

  Nov 7, 2021
• What are antiviral COVID-19 pills and how could they help?

  Public health experts have described the implementation of antiviral pills as potentially game-changing in the fight against the COVID-19 pandemic.

  Canada

  Nov 6, 2021
• Experimental pill fights COVID-19, drug-maker Merck claims

  Several other companies, including Pfizer and Roche, are studying similar drugs that could report results in the coming weeks and months.

  Health

  Oct 1, 2021